These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 7758881

  • 21. Insulin secretion and action and the response of endogenous glucose production to a lack of glucagon suppression in nondiabetic subjects.
    Adams JD, Egan AM, Laurenti MC, Schembri Wismayer D, Bailey KR, Cobelli C, Dalla Man C, Vella A.
    Am J Physiol Endocrinol Metab; 2021 Nov 01; 321(5):E728-E736. PubMed ID: 34658253
    [Abstract] [Full Text] [Related]

  • 22. Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
    Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli G.
    Diabetes Care; 1996 Sep 01; 19(9):945-52. PubMed ID: 8875087
    [Abstract] [Full Text] [Related]

  • 23. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.
    Gerich JE, Lorenzi M, Karam JH, Schneider V, Forsham PH.
    JAMA; 1975 Oct 13; 234(2):159-5. PubMed ID: 1242153
    [Abstract] [Full Text] [Related]

  • 24. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR, James FD, Lacy DB, Jabbour K, Williams PE, Fueger PT, Wasserman DH.
    Diabetes; 2004 Dec 13; 53(12):3041-7. PubMed ID: 15561932
    [Abstract] [Full Text] [Related]

  • 25. Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.
    Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, Rizza RA.
    Diabetes; 1997 Mar 13; 46(3):421-32. PubMed ID: 9032098
    [Abstract] [Full Text] [Related]

  • 26. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery.
    Holste LC, Connolly CC, Moore MC, Neal DW, Cherrington AD.
    Am J Physiol; 1997 Sep 13; 273(3 Pt 1):E488-96. PubMed ID: 9316437
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
    Shiota M, Galassetti P, Monohan M, Neal DW, Cherrington AD.
    Diabetes; 1998 Jun 13; 47(6):867-73. PubMed ID: 9604861
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
    Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C, Musi N, DeFronzo RA, Cersosimo E.
    Am J Physiol Endocrinol Metab; 2008 May 13; 294(5):E846-52. PubMed ID: 18334612
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
    Saccà L, Cicala M, Trimarco B, Ungaro B, Vigorito C.
    J Clin Invest; 1982 Jul 13; 70(1):117-26. PubMed ID: 6123524
    [Abstract] [Full Text] [Related]

  • 32. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production.
    Ader M, Bergman RN.
    Am J Physiol; 1990 Jun 13; 258(6 Pt 1):E1020-32. PubMed ID: 2193527
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S, Maifreni L, Lisato G, Riccio A, Trevisan R, Tiengo A, Del Prato S.
    J Clin Endocrinol Metab; 1990 Apr 13; 70(4):1023-9. PubMed ID: 2180971
    [Abstract] [Full Text] [Related]

  • 36. The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.
    Toft-Nielson M, Madsbad S, Holst JJ.
    Diabetes; 1996 May 13; 45(5):552-6. PubMed ID: 8621002
    [Abstract] [Full Text] [Related]

  • 37. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May 13; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.
    Diabetes; 2008 Jan 13; 57(1):24-31. PubMed ID: 17914032
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.